학술논문
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
Document Type
Article
Author
Catenacci, Daniel V T ; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E; Lee, Keun-Wook; Ng, Matthew C H; Enzinger, Peter C; Park, Se Hoon; Gold, Philip J; Lacy, Jill; Hochster, Howard S ; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A; Kelly, Ronan J; Juergens, Rosalyn A; Kim, Jong Gwang; Bendell, Johanna C; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A Craig; Knutson, Keith L; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K; Rosales, Minori Koshiji; Bang, Yung-Jue
Source
In The Lancet Oncology August 2020 21(8):1066-1076
Subject
Language
ISSN
1470-2045